Articles
Volume 9 Supplement 1
VII Madrid Breast Cancer Conference: Changes in the treatment of breast cancer
Meeting abstracts
VII Madrid Breast Cancer Conference: Changes in the treatment of breast cancer
Madrid, Spain
20-22 June 2007
The organisers would like to thank Novartis for funding publication of this abstract supplement.
|
Oral presentation
Assessing prognosis for early breast cancer: clinical versus genetic profiles GN Hortobagyi Breast Cancer Research 2007, 9(Suppl 1):S1 (19 June 2007) |
|
Oral presentation
Circulating tumor cells as predictors of recurrence in primary breast cancer W Janni Breast Cancer Research 2007, 9(Suppl 1):S2 (19 June 2007) |
|
Oral presentation
Circulating tumor and endothelial cells as predictors of response in metastatic breast cancer M Cristofanilli Breast Cancer Research 2007, 9(Suppl 1):S3 (19 June 2007) |
|
Oral presentation
Gene expression profiling for prognosis of breast cancer M van de Vijver Breast Cancer Research 2007, 9(Suppl 1):S4 (19 June 2007) |
|
Oral presentation
Molecular and gene expression-based predictors of response to preoperative chemotherapy L Pusztai Breast Cancer Research 2007, 9(Suppl 1):S5 (19 June 2007) |
|
Oral presentation
Role of MR and digital mammography for screening DD Dershaw Breast Cancer Research 2007, 9(Suppl 1):S6 (19 June 2007) |
|
Oral presentation
EP Mamounas Breast Cancer Research 2007, 9(Suppl 1):S7 (19 June 2007) |
|
Oral presentation
Treatment of the intact primary in women with metastatic breast cancer SA Khan, H Hazard, D Scholtens Breast Cancer Research 2007, 9(Suppl 1):S8 (19 June 2007) |
|
Oral presentation
Immediate versus delayed breast reconstruction GL Robb Breast Cancer Research 2007, 9(Suppl 1):S9 (19 June 2007) |
|
Oral presentation
The nipple sparing mastectomy: a 5-year experience at the European Institute of Oncology of Milan JY Petit, U Veronesi, R Orecchia, A Luini Breast Cancer Research 2007, 9(Suppl 1):S10 (19 June 2007) |
|
Oral presentation
Partial breast irradiation and intraoperative radiotherapy R Orecchia Breast Cancer Research 2007, 9(Suppl 1):S11 (19 June 2007) |
|
Oral presentation
Current status of adjuvant endocrine therapy for premenopausal patients with primary breast cancer A Howell Breast Cancer Research 2007, 9(Suppl 1):S12 (19 June 2007) |
|
Oral presentation
Triple-negative (basal-like) breast cancer: a new entity LA Carey Breast Cancer Research 2007, 9(Suppl 1):S13 (19 June 2007) |
|
Oral presentation
PF Conte, V Guarneri, C Bengala Breast Cancer Research 2007, 9(Suppl 1):S14 (19 June 2007) |
|
Oral presentation
Present and future role of bisphosphonates in treatment GN Hortobagyi Breast Cancer Research 2007, 9(Suppl 1):S15 (19 June 2007) |
|
Oral presentation
Standards and future strategies in adjuvant chemotherapy treatments C Hudis, H McArthur Breast Cancer Research 2007, 9(Suppl 1):S16 (19 June 2007) |
|
Oral presentation
Adjuvant hormonal therapy for postmenopausal women EP Winer Breast Cancer Research 2007, 9(Suppl 1):S17 (19 June 2007) |
|
Oral presentation
GN Hortobagyi Breast Cancer Research 2007, 9(Suppl 1):S18 (19 June 2007) |
|
Oral presentation
Neoadjuvant endocrine therapy: clinical and biological issues IE Smith Breast Cancer Research 2007, 9(Suppl 1):S19 (19 June 2007) |
|
Oral presentation
Chemotherapy in metastatic disease: an overview IE Smith Breast Cancer Research 2007, 9(Suppl 1):S20 (19 June 2007) |
